InflaRx NV buy Guggenheim
Start price
26.03.25
/
50%
€1.21
Target price
26.03.26
€9.27
Performance (%)
-35.50%
End price
27.03.26
€0.78
Summary
This prediction ended on 27.03.26 with a price of €0.78. Massive losses of -35.50% were the result for the BUY prediction by Guggenheim. Guggenheim has a follow-up prediction for InflaRx NV where he still thinks InflaRx NV is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| InflaRx NV | -24.467% | -24.467% | 103.279% |
| iShares Core DAX® | -2,20 % | 0,67 % | 0,55 % |
| iShares Nasdaq 100 | -2,63 % | 2,99 % | 34,11 % |
| iShares Nikkei 225® | -2,02 % | 3,14 % | 53,42 % |
| iShares S&P 500 | -1,67 % | 2,40 % | 23,22 % |
Comments by Guggenheim for this prediction
In the thread InflaRx NV diskutieren
InflaRx (NASDAQ: IFRX) had its price target raised by analysts at Guggenheim from $7.00 to $10.00. They now have a "buy" rating on the stock.
Ratings data for IFRX provided by MarketBeat
In the thread Trading InflaRx NV
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten